Search for: "Sam E. Antar"
Results 61 - 80
of 167
Sort by Relevance
|
Sort by Date
11 Oct 2010, 2:29 am
Written by: Sam E. [read post]
3 Oct 2010, 11:56 am
As a public company from 1984 to 1986, our frauds concentrated on inflating profits or overstating income to help certain members of the Antar family ultimately sell about $100 million in stock at inflated prices. [read post]
23 Sep 2010, 9:53 pm
Written by: Sam E. [read post]
18 Sep 2010, 5:58 pm
Medifast General Counsel Michael Tanczyn, Esq. at the deposition of Sam Antar. [read post]
16 Sep 2010, 12:59 am
Written by, Sam E. [read post]
12 Sep 2010, 8:57 am
Written by, Sam E. [read post]
6 Aug 2010, 9:45 am
Sam E. [read post]
3 Aug 2010, 11:01 pm
Written by: Sam E. [read post]
26 Jul 2010, 5:59 pm
Written by, Sam E. [read post]
25 Jul 2010, 1:08 am
” Written by: Sam E. [read post]
19 Jul 2010, 11:21 pm
Written by: Sam E. [read post]
15 Jul 2010, 10:50 pm
Written by: Sam E. [read post]
7 Jul 2010, 11:10 am
Written by: Sam E. [read post]
27 Jun 2010, 4:05 am
To SEC Chairperson Mary Schapiro: In August 2009, I wrote my first Open Letter to the Securities and Exchange Commission detailing how Overstock.com deliberately violated Generally Accepted Accounting Principles (GAAP) in recognizing income for recoveries from underbilled fulfillment partners by improperly claiming that a “gain contingency” existed under accounting rules. [read post]
22 Jun 2010, 4:11 pm
Written by: Sam E. [read post]
20 Jun 2010, 6:32 pm
To Securities and Exchange Commission Chief Accountant Wayne Carnall: In my first Open Letter, I asked the Securities and Exchange Commission Division of Corporation Finance to review Medifast's (NYSE: MED) revenue recognition policy to determine if it complies with Generally Accepted Accounting Principles (GAAP) and SEC Staff Accounting Bulletin Topic 13. [read post]
17 Jun 2010, 3:34 am
Respectfully: Sam E. [read post]
15 Jun 2010, 5:58 pm
Borne and its CFO Dale E. [read post]
13 Jun 2010, 10:16 am
To the Securities and Exchange Commission Chief Accountant Wayne Carnall: Based on my analysis of Medifast’s (NYSE: MED) financial disclosures below, I respectfully recommend that the Division of Corporation Finance immediately review the company’s revenue recognition policy, before it issues its Q2 2010 10-Q report. [read post]
9 Jun 2010, 12:06 am
Written by: Sam E. [read post]
